Haemtech Biopharma Services
News/Events

Haematologic Technologies Adds a High Resolution Mass Spectrometry Lab

Expanded Capabilities add to HTI’s Growing Large Molecule Bioanalysis Services Business September 30th, 2020 Essex Junction, VT –Haematologic Technologies (HTI), a leading protein chemistry company providing products and analytical services supporting the research, development, and commercialization of large molecule biotherapeutics,

Read more ›

Haematologic Technologies Appoints Steve Pemberton as Vice President of Commercial Development

August 31th , 2020 Essex Junction, VT – Haematologic Technologies (HTI), a leading protein chemistry company providing products and analytical services supporting the research, development, and commercialization of large molecule biotherapeutics, today announced the expansion of the Senior Leadership Team

Read more ›

Haematologic Technologies Announces Jean Pineault as President and Chief Executive Officer

June 1, 2020, Essex Junction, VT – Haematologic Technologies (HTI), a leading provider of products and analytical services supporting the research, development, and commercialization of large molecule biotherapeutics, today announced that Jean Pineault has been appointed President & CEO. Jean

Read more ›

Edgewater Capital Partners to Acquire Haematologic Technologies

Joint News Release HTI Media Contact:Robert Myers, VP of Business DevelopmentTel.: (802) 878-1777Email: [email protected] Edgewater Media Contact:Robert Girton, PartnerTel.: (216) 292-3858Email: [email protected] Edgewater Capital Partners to Acquire Haematologic Technologies Essex Junction, VT and Cleveland, OH, October 11, 2019 – Edgewater

Read more ›

Haemtech needs QC Specialists

QC Specialist! The Quality Control Specialist is responsible for generating and/or reviewing data under cGMP guidelines. Experience is running ELISA/microplate-based assays is a plus. The Quality Control Specialist must be able to read and understand technical documents including, training documents,

Read more ›